One in six children on GLP-1 drugs developed health problems within a year

A study found that nearly one in six children taking GLP-1 drugs such as semaglutide developed a specific health problem within a year of starting treatment. Researchers note that many young patients do not receive dietary counseling alongside the therapy. The results suggest a need for closer medical oversight of children using these medications.